Evidence map›Paper›PMID 41724382›Full record

ArticleThe Journal of biological chemistry2026

Phosphorylation of inner core heptose is a major determinant of bacterial surface lipopolysaccharide recognition by the innate immune protein hSP-D.

Harry M Williams, Alastair Watson, Jens Madsen, Howard W Clark, Derek W Hood, Stefan Oscarson, Trevor J Greenhough, Annette K Shrive

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Harry M WilliamsSchool of Life Sciences, Keele University, Staffordshire, UK.
Alastair WatsonDivision Faculty of Medicine, Department of Child Health, University of Southampton, Hampshire, UK; School of Clinical Medicine, University of Cambridge, Cambridge, UK.
Jens MadsenTargeted Lung Immunotherapy Group, Neonatology, The EGA Institute for Women's Health, University College London, London, UK.
Howard W ClarkTargeted Lung Immunotherapy Group, Neonatology, The EGA Institute for Women's Health, University College London, London, UK.
Derek W HoodMammalian Genetics Unit, MRC Harwell Institute, Harwell Science and Innovation Campus, Oxfordshire, UK.
Stefan OscarsonCentre for Synthesis and Chemical Biology, University College Dublin, Belfield, Dublin, Ireland.
Trevor J GreenhoughSchool of Life Sciences, Keele University, Staffordshire, UK.
Annette K ShriveSchool of Life Sciences, Keele University, Staffordshire, UK. Electronic address: a.k.shrive@keele.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The innate immune protein human surfactant protein D (SP-D) recognizes pathogens in the lungs via binding to carbohydrate surface structures. SP-D targets gram-negative bacterial lipopolysaccharide via calcium-dependent binding, preferentially to the inner core heptose (HepI). To further investigate this recognition, we have determined the high-resolution crystal structures of a trimeric recombinant fragment of human SP-D complexed with synthetic di-saccharide and trisaccharides, HepI-Kdo, HepIII-HepII-HepI, and HepII-HepI phosphorylated at either HepI or HepII, inner core lipopolysaccharide motifs common to many gram-negative bacteria. In contrast to acid-hydrolyzed lipopolysaccharide used in several previous studies, these synthetic saccharides allow the presentation of both the innermost Kdo in its natural pyranose form and heptose phosphorylation. The structures confirm the flexibility of SP-D to adopt alternative binding modes when the preferred epitope is not available, reveal a preference for recognition of the reducing terminal heptose (HepI) via the glyceryl group, indicate that a single Kdo attached to HepI does not have a significant role in ligand recognition, and provide evidence that heptose phosphorylation is a major determinant of recognition. The disaccharide with HepII O4' phosphorylation binds via the preferred HepI glyceryl-hydroxyls, while HepI O4' phosphorylation reveals HepII binding via the pyranose ring O3' and O4' hydroxyls, which would not be possible with the usual HepII O3' link to the outer core. The ability of HepI O4' phosphorylation to prevent preferred HepI recognition suggests a role for heptose phosphorylation in shielding the bacterial LPS inner core from immune recognition.

Indexed as

HeptosesImmunity, InnateLipopolysaccharidesPulmonary Surfactant-Associated Protein DCrystallography, X-RayHumansInnate Immunity RecognitionModels, MolecularPhosphorylationHeptosesLipopolysaccharidesPulmonary Surfactant-Associated Protein Dcrystal structurehost–pathogen interactioninnate immunitylipopolysaccharide-binding proteinstructural biologysurfactant protein D

Identifiers

PMID41724382
PMCPMC13015573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.